We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares

90 hedge funds and large institutions have $938M invested in Lakefront Biotherapeutics American Depositary Shares in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

18% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 28

0% more funds holding

Funds holding: 9090 (0)

0.2% less ownership

Funds ownership: 47.64%47.44% (-0.2%)

9% less capital invested

Capital invested by funds: $1.03B → $938M (-$92.8M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

98% less call options, than puts

Call options by funds: $303K | Put options by funds: $16.2M

Holders
90
Holders Change
Holders Change %
0%
% of All Funds
1.1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
16
Increased
33
Reduced
28
Closed
13
Calls
$303K
Puts
$16.2M
Net Calls
-$15.9M
Net Calls Change
-$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
26
Barometer Capital Management
Ontario, Canada
$1.14M +$33.1K +1,000 +3%
CGH
27
Crossmark Global Holdings
Texas
$978K -$12.3K -370 -1%
MAM
28
Monaco Asset Management
Monaco
$826K -$166K -5,000 -15%
Morgan Stanley
29
Morgan Stanley
New York
$799K -$1.38M -41,666 -61%
Optiver Holding
30
Optiver Holding
Netherlands
$796K +$879K +26,535 New
Two Sigma Investments
31
Two Sigma Investments
New York
$776K +$315K +9,500 +58%
XT
32
XTX Topco
Cayman Islands
$762K +$72.3K +2,185 +9%
MNBTD
33
Moody National Bank Trust Division
Texas
$625K
Bank of America
34
Bank of America
North Carolina
$622K -$339K -10,244 -33%
QCM
35
QRG Capital Management
Illinois
$591K +$117K +3,535 +22%
PCM
36
Prelude Capital Management
New York
$579K
Jane Street
37
Jane Street
New York
$408K +$451K +13,607 New
Voloridge Investment Management
38
Voloridge Investment Management
Florida
$405K -$1M -30,351 -69%
EAM
39
Erste Asset Management
Austria
$404K
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$402K +$213K +6,419 +92%
Squarepoint
41
Squarepoint
New York
$389K +$429K +12,952 New
AA
42
ABC Arbitrage
France
$382K +$422K +12,744 New
ACM
43
Aquatic Capital Management
Illinois
$356K -$61.4K -1,853 -14%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$339K +$6.42K +194 +2%
DO
45
denkapparat Operations
Germany
$319K +$352K +10,636 New
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$315K +$54.2K +1,638 +18%
Cerity Partners
47
Cerity Partners
New York
$309K +$341K +10,310 New
Geode Capital Management
48
Geode Capital Management
Massachusetts
$305K +$76.1K +2,299 +29%
COPPSERS
49
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$248K +$274K +8,273 New
BCI
50
Brinker Capital Investments
Pennsylvania
$223K +$246K +7,426 New

LKFT Hedge Fund Activity: Q1 2026 in Review

90 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q1 2026, worth a combined $938M — down 9% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LKFT positions and 13 closed out — a net gain of 3 holders — while 33 added to existing stakes and 28 trimmed.

The largest buyer was Prosight Management, adding an estimated $15.8M. The largest seller was Millennium Management, cutting an estimated $7.66M.

  • 90 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $938M of Lakefront Biotherapeutics American Depositary Shares stock for Q1 2026, down 9% quarter-over-quarter.
  • 16 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q1 2026 and 13 closed out, a net change of +3 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q1 2026 was Prosight Management, an estimated $15.8M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q1 2026 was Millennium Management, an estimated $7.66M sold.

Based on aggregated 13F filings for Q1 2026.